CorMedix (CRMD)

NASDAQ 1 marketed · 1 in Phase 3

Quick facts

Ticker	CRMD (NASDAQ)

Marketed products

Taurolidine and Heparin

Phase 3 pipeline

Neutrolin · Other

Phase 2 pipeline

CRMD-001-Deferiprone · Rare Disease
Iron chelator

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: